Cue Biopharma Inc. – Filings and Transcripts

NASDAQ: CUE
Share price (11/5/26): $18.01
Market cap (11/5/26): $131 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration

Exempt offering of securities

Shelf registration

Registration of securities for employees

Shelf registration

Ownership Filter

Meluzio Michael Vincent

News Filter

Announces Positive Topline Results From CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria

Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Change in Directors, Officers or Compensation

Announces $50.0 Million Private Placement

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC